Treatment management for BRAF -mutant melanoma patients with tumor recurrence on adjuvant therapy: A multicenter study from the prospective skin cancer registry ADOREG
Maximilian Haist*, Henner Stege, Friederike Rogall, Yuqi Tan, Imke Von Wasielewski, Kai Christian Klespe, Friedegund Meier, Peter Mohr, Katharina C. Kähler, Michael Weichenthal, Axel Hauschild, Dirk Schadendorf, Selma Ugurel, Georg Lodde, Lisa Zimmer, Ralf Gutzmer, Dirk Debus, Bastian Schilling, Alexander Kreuter, Jens Ulrich
*Corresponding author for this work
- Johannes Gutenberg University Mainz
- Stanford University
- Hannover Medical School
- Universitätsklinikum Carl Gustav Carus
- Germany: German Cancer Research Center (DKFZ)
- Elbe-Kliniken
- University of Kiel
- University of Duisburg-Essen
- Ruhr-University Bochum
- Nuremberg Hospital
- University of Würzburg
- University Witten/Herdecke
- Harzklinikum Dorothea Christiane Erxleben GmbH
- University of Freiburg
- HELIOS Klinikum Erfurt
- University of Tubingen
- Saarland University
- DRK Hospital Chemnitz-Rabenstein
- DRK Krankenhaus Rabenstein
- Ruprecht-Karls Universität Heidelberg
- Hildesheim Clinic
- Bremerhaven Reinkenheide Hospital
- Klinikum der Stadt Ludwigshafen
- University of Erlangen–Nuremberg
- Vivantes Auguste-Viktoria-Klinikum
- University of Regensburg
- University Hospital Hamburg-Eppendorf
- Gesundheit-Nord Hospital
20
Link opens in a new tab
Citations
(Scopus)